[Skip to Content]
[Skip to Content Landing]

December 2018 - April 2016

Decade

Year

Issue

January 2019, Vol 4, No. 1, Pages 3-84

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2019;4(1):3. doi:10.1001/jamacardio.2018.3175
Original Investigation

Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial

Abstract Full Text
JAMA Cardiol. 2019;4(1):7-15. doi:10.1001/jamacardio.2018.4171

This analysis of data from the EUCLID trial characterizes the incidence and types of myocardial infarction in patients with peripheral artery disease, identifies factors associated with myocardial infarction, and determines the association of myocardial infarction with cardiovascular mortality and acute limb ischemia.

Association of Hospital Surgical Aortic Valve Replacement Quality With 30-Day and 1-Year Mortality After Transcatheter Aortic Valve Replacement

Abstract Full Text
JAMA Cardiol. 2019;4(1):16-22. doi:10.1001/jamacardio.2018.4051

This national cohort study assesses the quality of hospital outcomes by determining the correlation between mortality after surgical aortic valve replacement procedures and mortality at 30 days and 1 year after transcathether aortic valve replacement procedures.

Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure

Abstract Full Text
open access has active quiz has audio
JAMA Cardiol. 2019;4(1):25-33. doi:10.1001/jamacardio.2018.3965

This study assesses the potential prognostic significance of clonal hematopoiesis of indeterminate potential in patients with chronic heart failure owing to ischemic origin.

Long-term Outcomes of Tetralogy of Fallot: A Study From the Pediatric Cardiac Care Consortium

Abstract Full Text
JAMA Cardiol. 2019;4(1):34-41. doi:10.1001/jamacardio.2018.4255

This study evaluates the long-term transplant-free survival of tetralogy of Fallot by surgical strategy adjusted for era and patient characteristics.

Association of Educational Attainment and Cardiovascular Risk in Hispanic Individuals: Findings From the Cooper Center Longitudinal Study

Abstract Full Text
JAMA Cardiol. 2019;4(1):43-50. doi:10.1001/jamacardio.2018.4294

This cohort study determines cardiovascular risk and outcomes among highly educated Hispanic and non-Hispanic white individuals who participated in a preventive medicine clinic.

Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study

Abstract Full Text
JAMA Cardiol. 2019;4(1):51-58. doi:10.1001/jamacardio.2018.4300

This longitudinal cohort study explores the association of left ventricular hypertrophy and high-sensitivity cardiac troponin I levels and the risk of heart failure among African Americans enrolled in the Jackson Heart Study.

Brief Report

Interindividual Variation in Low-Density Lipoprotein Cholesterol Level Reduction With Evolocumab: An Analysis of FOURIER Trial Data

Abstract Full Text
JAMA Cardiol. 2019;4(1):59-63. doi:10.1001/jamacardio.2018.4178

This study evaluates the interindividual variability in low-density lipoprotein cholesterol reduction with the PCSK9 inhibitor drug evolocumab.

Outcomes From Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis and Left Ventricular Ejection Fraction Less Than 30%: A Substudy From the TOPAS-TAVI Registry

Abstract Full Text
JAMA Cardiol. 2019;4(1):64-70. doi:10.1001/jamacardio.2018.4320

This multicenter registry study evaluates the clinical outcomes and changes in left ventricular ejection fraction after transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis and severe left ventricular dysfunction.

Editorial

CHIPping Away at the Pathogenesis of Heart Failure

Abstract Full Text
has audio
JAMA Cardiol. 2019;4(1):5-6. doi:10.1001/jamacardio.2018.4039
Invited Commentary

Has a New Determinant of Transcatheter Aortic Valve Replacement Outcomes Been Identified?

Abstract Full Text
JAMA Cardiol. 2019;4(1):22-24. doi:10.1001/jamacardio.2018.4170

Residual Risk After Tetralogy of Fallot Repair

Abstract Full Text
JAMA Cardiol. 2019;4(1):41-42. doi:10.1001/jamacardio.2018.4331
Review

Durability Data for Bioprosthetic Surgical Aortic Valve: A Systematic Review

Abstract Full Text
JAMA Cardiol. 2019;4(1):71-80. doi:10.1001/jamacardio.2018.4045

This systematic review analyzes available data on structural valve deterioration of surgical bioprosthetic aortic valves by examining the published literature as well as data reported to the US Food and Drug Administration.

JAMA Cardiology Clinical Challenge

A 71-Year-Old Man With Inferior ST-Segment Elevation

Abstract Full Text
has active quiz has multimedia
JAMA Cardiol. 2019;4(1):81-82. doi:10.1001/jamacardio.2018.2837

A 71-year-old man presented with a 3-hour history of central chest pain associated with breathlessness and inferior ST-segment elevation. What would you do next?

Comment & Response

Inconsistent Reporting of Potential Conflicts of Interest in JAMA Cardiology

Abstract Full Text
JAMA Cardiol. 2019;4(1):84. doi:10.1001/jamacardio.2018.4194
Correction

Errors in Figure Label and Caption

Abstract Full Text
free access
JAMA Cardiol. 2019;4(1):84. doi:10.1001/jamacardio.2018.3643

Inconsistent Reporting of Potential Conflicts of Interest Disclosure

Abstract Full Text
free access
JAMA Cardiol. 2019;4(1):84. doi:10.1001/jamacardio.2018.4232
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2019;4(1):4. doi:10.1001/jamacardio.2018.3176
×